Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Introduction Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD), is a significant and rapidly increasing health concern in developed nations, becoming a leading cause of liver-related mortality. Its prevalence is also soaring in developing regions, highlighting the global impact of this condition (1). Albeit the alteration in nomenclature, the discernments pertaining to NAFLD remain pertinent to MASLD (2).
Introduction Currently, the global population is experiencing a growing trend of aging. In 2019, the global population of older adults was approximately 700 million (1). China, being the most populous country in the world, also has the largest elderly population. By the end of 2015, there were 143.9 million elderly adults in China, aged 65 years or older, comprising 10.5% of the total population (2).
1. Introduction After the age of 50, muscle mass declines at a rate of 1%−2% per year in healthy adults, while muscle strength declines at a rate of 1.5% per year (1, 2). Sarcopenia was defined by the European Working Group on Sarcopenia in Older People (EWGSOP) in 2010 as “a syndrome characterized by progressive and generalized loss of skeletal muscle mass and strength with a risk of adverse outcomes such as physical disability, poor quality of life, and death” (3).
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
